We use cookies to improve your website experience. To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy. By closing this message, you are consenting to our use of cookies.

Preventive Oncology & Epidemiology

An Open Access Journal

The number of new cancer cases per year is expected to rise to more than 29 million by 2040, a 62% increase in the number of new cancer cases diagnosed in 2018. This is a startling statement, especially given that cancer is now estimated to impact 1 in 2 of the population during their lifetime. 

Preventive Oncology & Epidemiology, a new open access journal from Taylor and Francis, is focused on disseminating research as quickly and as widely as possible, advancing innovations within cancer epidemiology and prevention. By facilitating the dissemination of cutting edge research, we can improve our understanding of the epidemiology and prevention of cancer, significantly reducing premature mortality across the globe.

Meet the Editor

Electra D. Paskett, Ph.D., became the Marion N. Rowley Professor of Cancer Research at The Ohio State University in 2002. She is the Director of the Division of Cancer Prevention and Control in the College of Medicine, a professor in the Division of Epidemiology, College of Public Health and the Associate Director for Population Sciences and Community Outreach and Co-Program Leader of the Cancer Control Program in the Comprehensive Cancer Center of the Ohio State University (OSU). 

She is also Founding Director of the Center for Cancer Health Equity at the James Cancer Hospital. She received her doctorate in epidemiology from the University of Washington. Dr. Paskett’s almost 400 peer-reviewed publications showcase her work in intervention research directed at cancer prevention, early detection and survivorship issues. Her studies use multi-level interventions in transdisciplinary teams with community-based participatory research to identify and intervene on factors causing disparities among underserved populations such as social and ethnic minority groups and rural/underserved populations.

Dr. Paskett successfully competed for an NCI-funded P50, Center for Population Health and Health Disparities, to examine why rates of cervical cancer are high in Appalachia Ohio and is the Multiple Principal Investigator (MPI) of a large cervical cancer prevention program project in Appalachian regions of four states. In 2016, she was appointed by President Obama as a member of the National Cancer Institute’s National Cancer Advisory Board, and in 2022 she was re-appointed by Governor Mike DeWine as a member of the Ohio Commission on Minority Health.

More about the journal

Preventive Oncology & Epidemiology is an online, open access journal publishing original research, reviews, commentaries and study protocols across all areas of cancer epidemiology and prevention.

Cancer epidemiology is defined as the study of the distribution and determinants of cancer(s), allowing researchers to ascertain the possible trends and causes of cancer development amongst different populations. Cancer prevention focuses on identifying possible candidates for preventing cancer and testing interventions to reduce the risk of developing cancer. This includes behavioral factors (for example, diet, exercise, obesity prevention, sun protection, and tobacco use), chemoprevention, the use of vaccines, and the uptake of cancer screening/early detection tests. Furthermore, cancer prevention includes intervention research (patient navigation, computer-aided reminders, clinic and provider-based programs for example), as well as the validation and use of early detection tests and biomarkers.

Promoting collaboration across all disciplines, from nutrition to cancer health policy, Preventive Oncology & Epidemiology is the home for researchers dedicated to advancing innovations within cancer epidemiology and prevention.

    Topics covered include, but are not limited to:

    • Research focusing on early detection strategies, such as screening programmes, as well as the identification/validation of novel biomarkers that could lead to the creation of innovative early detection diagnostics;

    • The implementation of interventions and programmes at a community, state, or country level. The journal also wishes to highlight the barriers associated with implementing community health interventions and the unique challenges impacting underserved and minority populations and different settings;

    • The implications of state or country health policies on cancer epidemiology and prevention efforts;

    • Research focusing on geographical variations and trends in cancer distribution, within and between populations, at the state or country level; and

    • Community education and engagement strategies to raise awareness of lifestyle risk factors, prevention, and early detection strategies.

    The journal accepts the following article types: Original Research, Reviews (systematic and meta-analyses), Brief Reports, Letters to the Editor, Commentaries, and Study Protocols.

      Preventive Oncology & Epidemiology operates a single-blind peer review policy. All articles will be made freely and permanently available online through gold open access publication.

      Why publish open access?

      • Increase the visibility and readership of your research by publishing in a fully open access journal.

      • Make an impact beyond the academy by making your article accessible to anyone, anywhere (including readers in industry and even policy-makers).

      • Freely share your work with no restrictions or paywall.

      • Retain ownership of your research through our unrestrictive publishing agreements.

      • Discounts and waivers for researchers in developing countries are available. The journal will also consider requests for discretionary APC waivers. Find out if your institution or country has an open access agreement to publish with us.

        Joanne was a wonderful person and impressive scientist. My condolences go to Shelley and her family, friends and colleagues. She will be missed. https://t.co/80sWkbFdZV
        November 18

        We use cookies to improve your website experience. To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy. By closing this message, you are consenting to our use of cookies.